[Pseudohyperaldosteronism by chronic overdose of "Pulmoll" expectorant lozenges].
Lévesque
H
H
Cailleux
N
N
Poutrain
J R
JR
Noblet
C
C
Moore
N
N
Courtois
H
H
D000368:Aged; D000890:Anti-Infective Agents / Q000009:adverse effects*; D002908:Chronic Disease; D062787:Drug Overdose / Q000150:complications; D005100:Expectorants / Q000009:adverse effects*; D006034:Glycyrrhetinic Acid / Q000009:adverse effects / Q000031:analogs & derivatives*; D019695:Glycyrrhizic Acid; D006801:Humans; D006929:Hyperaldosteronism / Q000139:chemically induced*; D008297:Male; D013607:Tablets
D000890:Anti-Infective Agents; D005100:Expectorants; D013607:Tablets; D019695:Glycyrrhizic Acid; D006034:Glycyrrhetinic Acid
Pseudohyperaldostéronisme par surdosage chronique en pastilles "Pulmoll" marron.